A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls.
about
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disordersFrontotemporal Lobar Degeneration and MicroRNAsHippocampal sclerosis of aging, a prevalent and high-morbidity brain diseaseCirculating microRNAs in Alzheimer's disease: the search for novel biomarkersAlteration of the microRNA network during the progression of Alzheimer's disease.Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.MicroRNAs targeting Nicastrin regulate Aβ production and are affected by target site polymorphismsThe emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disordersEpigenomics of Alzheimer's disease.Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia.Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression.The TMEM106B locus and TDP-43 pathology in older persons without FTLDPlasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.Novel microRNA discovery using small RNA sequencing in post-mortem human brain.Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment.miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy.Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's DiseasePlasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study.MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjectsExpression of miR-15/107 family microRNAs in human tissues and cultured rat brain cells."New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS).miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's diseasemiR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain.microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic mice.Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease.Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease.MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls.Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis.Whole transcriptome profiling of Late-Onset Alzheimer's Disease patients provides insights into the molecular changes involved in the disease.Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain.
P2860
Q21129476-3B45C1E5-7938-446C-84F4-DD5E55246337Q26768177-0307E6F2-CBD9-4E0F-85D8-6ACE6D44DF4FQ26996741-87379100-5AE6-4892-83E3-F5D9A834A597Q27021084-7DF8F812-9F45-4BAD-9430-17F0E2546DE3Q30551542-3AA5D53D-566D-40C3-AD19-83A6A89E02B1Q33738316-73E15570-D86D-4A96-97C2-BDD76277CC1CQ33920169-EBBCF8BA-A5F2-40AF-9BD9-DEF09B343950Q34353055-F84E5C39-7A35-4241-BBDD-37FC54FACC0CQ34518584-9DCCD765-DBE8-424D-BDE8-8BFED4385D9EQ34642142-4D49570F-6E03-446F-B88C-9E4EF3DF040AQ35111407-CFFA237E-93B0-4A56-BD3D-11F6FF60825BQ35153681-393F27F8-2BDB-44D1-B254-91B552B26ECBQ35795155-92B00F27-B984-421C-9FCB-6F1F0DA6BAC2Q36156835-79A3C522-A62B-4A03-9CB0-47BA7B4B068FQ36249445-9BA47C1C-5674-468A-BB70-DF4B9DB85FCEQ36251998-91AE3F05-79B7-40A7-9DBD-12D51557CC28Q36695844-D9438938-2D21-4827-8F0F-0B8F83ACDFF3Q36939748-9F18D07E-A32C-4880-9A4C-F28FCD7E6D75Q37445069-28BA3852-B99D-4C0F-8D7A-BD3EE236D7D8Q37596385-3378573C-4229-467C-99FC-B012BB148CD5Q37685064-25050773-CA52-4B17-BE60-B44D429C689EQ38841003-F3783AAE-2AA2-452E-AD2D-F9E61C5B7DEBQ39742529-09EC7847-A001-4C35-8013-980D28839EBEQ41005799-D6F5AA38-0975-472D-B8F8-A51C13787962Q42384091-D1D0F229-A062-4C74-8056-F7103256C8AEQ43154122-B157DDD2-5C9E-400F-BE1D-5D1650B60B69Q46343789-A59BC3A8-49C9-42F3-8566-878BE4C6247CQ47214829-D751E684-2986-4F52-83BE-DF0FAB4718F4Q47550368-DFC0467D-4620-48FA-BBF6-B83E31360033Q50531480-99BF2BEB-24C3-48E9-A59E-0955AA977F51Q55264440-0D006004-94BB-46D1-8B49-850E29E550F5
P2860
A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A study of small RNAs from cer ...... d non-demented human controls.
@en
A study of small RNAs from cer ...... d non-demented human controls.
@nl
type
label
A study of small RNAs from cer ...... d non-demented human controls.
@en
A study of small RNAs from cer ...... d non-demented human controls.
@nl
prefLabel
A study of small RNAs from cer ...... d non-demented human controls.
@en
A study of small RNAs from cer ...... d non-demented human controls.
@nl
P2860
P921
P356
P1476
A study of small RNAs from cer ...... nd non-demented human controls
@en
P2093
Peter T Nelson
P2860
P304
P356
10.3233/JAD-122350
P577
2013-01-01T00:00:00Z